维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="Weickhardt"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer显示文摘	Andrew J. Weickhardt Benjamin Scheier Joseph Malachy Burke Gregory Gan Xian Lu Paul A. Bunn Dara L. Aisner Laurie E. Gaspar Brian D. Kavanagh Robert C. Doebele D. Ross Camidge	2012	Journal of Thoracic Oncology2012，，12：	3
2	Strategies for overcoming inherent and acquires resist- ance to EGFR inhihitors by targeting downstream effectors in the RAS/PI3K pathway显示文摘	WEICKHARDT A J TEBBUTT N C MARIADASON J M	2010	Current Cancer Drug Targets2010，10，8：	1
3	Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nons- mall cell lung cancer显示文摘	Weickhardt AJ Rothman MS Salian-Mehta S	2012	Cancer2012，，：	1
4	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer显示文摘	Weickhardt AJ Scheier B Burke JM	2012	J 'Ihorac Oncol2012，7，18：	1
5	Strate-gies for overcoming inherent and acquired resistance to EGFR in-hibitors by targeting downstream effectors in the RAS/PI3K path-way 显示文摘	WEICKHARDT AJ TEBBUTT NC MARIADASON JM	2010	Curr Cancer Drug Tar2010，10，8：	1
6	Oxaliplatin-induced neuropathy in colorectal cancer显示文摘	Weickhardt A Wells K Messersmith W		0，，：	1
7	Laser ion sources for time-of-flight mass spectrometry显示文摘	BOESL U WEINKAUL R WEICKHARDT C	1994	Int J Mass Spectrom1994，133，：	1
8	Time-of-Flight Mass Spectrometry: State-of-the-Art in Chemical Analysis and Molecular Science 显示文摘	Weickhardt C Moritz F and Grotemeyer J	1996	Mass Spectrometry Reviews1996，15，3：	1
9	Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer显示文摘	Weickhardt AJ Aisner DL Franklin WA	2013	Cancer2013，119，8：	1
10	Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC) :Analysis of the phase Ⅲ MAX study 显示文摘	Weickhardt AJ Williams D Lee C	2011	J Clin Oncol2011，1，：	1
11	Diagnostic assays for identification of anaplastic lymphoma kinase - positive non - small cell lung cancer显示文摘	Weickhardt A J Aisner D L Franklin W A	2013	Cancer2013，119，8：	1
12	Continuation ofEGFR/ALK inhibition after local therapy of oligoprogressivedisease in EGFR mutant ( Mt) and ALK + non-small cell lungcancer (NSCLC) 显示文摘	Weickhardt AJ Scheler B Burke JM	2012	J Clin Oncol2012，，：	1
13	Vascular endo- thelial growth factors (VEGF)and VEGF receptor expres- sion as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer ( mCRC ) : Analysis of the phase 111 MAX study显示文摘	Weickhardt ALl Williams D Lee C	2011	J Clin Oncoi2011，，：	1
14	Crizotinib for the treatment of patients with advanced non-small cell lung cancer显示文摘	Bowles DW Weickhardt AJ Doebele RC	2012	Drugs of Today2012，48，4：	1
15	Response to crizo- tinib rechallenge after initial progression and intervening chemo- therapy in ALK lung cancer显示文摘	Browning ET Weickhardt AJ Gamidge DR	2013	J Thorac Oncol2013，8，3：	1
16	Ion mobility spectrometry of laser desorbed pesticides from fruit surfaces显示文摘	WEICKHARDT C KAISER N BORSDORF H	2012	International Journal for Ion Mobility Spectrometry2012，15，：	1
17	A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer显示文摘	Andrew Weickhardt Robert Doebele Ana Oton Janice Lettieri DeLee Maxson Michele Reynolds Amy Brown Mary K. Jackson Grace Dy Araba Adjei Gerald Fetterly Xian Lu Wilbur Franklin Marileila Varella-Garcia Fred R. Hirsch Murry W. Wynes Hagop Youssoufian Alex Ad	2012	Journal of Thoracic Oncology2012，，2：	1
18	Drug-induced reduction in estimated glomerular filtration rate in patients with ALK- positive non-small cell lung cancer treated with the ALK inhibitor crizotinib显示文摘	Brosnan EM Weickhardt A J Lu X	2014	Cancer2014，120，5：	1
19	Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib显示文摘	Brosnan EM Weickhardt AJ Lu X	2014	Cancer2014，120，5：	1
20	The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence显示文摘	Weickhardt A J Camidge DR	2011	Clin Invest2011，1，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示